Eight of 38 patients (21%) with familiar and 5 of 175 patients (3%) wi
th sporadic amyotrophic lateral sclerosis (ALS) had missense mutations
in the SOD-1 gene. Two novel mutations were identified. One in exon 4
substituting leucine with phenylalanine (L84F) in a familial patient
and the second in exon 3 at substituting glycine with serine (G72S) in
an ''apparently'' sporadic patient. Over 60 point mutations have now
been described in all five exons of SOD-1, involving 43 of the 153 res
idues. Hypotheses about the toxic role of mutant SOD-1 in the pathogen
esis of ALS must account for this molecular diversity.